Equitec Proprietary Markets’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-153,610
Closed -$27.6M 108
2017
Q3
$27.6M Buy
+153,610
New +$21.4M 6.5% 5

Equitec Proprietary Markets's KITE Position: Q4 2017 in Review

Equitec Proprietary Markets sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 153,610 shares — an estimated $27.6M sold.

Equitec Proprietary Markets first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $27.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Equitec Proprietary Markets reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Equitec Proprietary Markets sold 153,610 Kite Pharma, Inc. shares in Q4 2017, an estimated $27.6M.
  • Equitec Proprietary Markets first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Equitec Proprietary Markets's Kite Pharma, Inc. position peaked at $27.6M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Equitec Proprietary Markets's 13F filing for Q4 2017, filed 24 Jan 2018.